# ID HBV Vaccination With Imiquimod in OBI

> **NCT03307902** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 120 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Imiquimod + ID HBVv
- **BIOLOGICAL:** Aqueous + ID HBVv
- **BIOLOGICAL:** Imiquimod + IM HBVv

## Key facts

- **NCT ID:** NCT03307902
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03307902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03307902, "ID HBV Vaccination With Imiquimod in OBI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03307902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*